These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 34324432)
1. Prevalence and risk factors of hypothalamic-pituitary dysfunction in infant and toddler childhood brain tumor survivors. Lebbink CA; Ringers TP; Schouten-van Meeteren AYN; van Iersel L; Clement SC; Boot AM; Claahsen-van der Grinten HL; Janssens GO; van Vuurden DG; Michiels EM; Han KS; van Trotsenburg ASP; Vandertop WP; Kremer LCM; van Santen HM Eur J Endocrinol; 2021 Sep; 185(4):597-606. PubMed ID: 34324432 [TBL] [Abstract][Full Text] [Related]
2. High Prevalence of Weight Gain in Childhood Brain Tumor Survivors and Its Association With Hypothalamic-Pituitary Dysfunction. van Schaik J; van Roessel IMAA; Schouten-van Meeteren NAYN; van Iersel L; Clement SC; Boot AM; Claahsen-van der Grinten HL; Fiocco M; Janssens GO; van Vuurden DG; Michiels EM; Han SKS; van Trotsenburg PASP; Vandertop PWP; Kremer LCM; van Santen HM J Clin Oncol; 2021 Apr; 39(11):1264-1273. PubMed ID: 33621126 [TBL] [Abstract][Full Text] [Related]
3. Hypothalamic-Pituitary Disorders in Childhood Cancer Survivors: Prevalence, Risk Factors and Long-Term Health Outcomes. van Iersel L; Li Z; Srivastava DK; Brinkman TM; Bjornard KL; Wilson CL; Green DM; Merchant TE; Pui CH; Howell RM; Smith SA; Armstrong GT; Hudson MM; Robison LL; Ness KK; Gajjar A; Krull KR; Sklar CA; van Santen HM; Chemaitilly W J Clin Endocrinol Metab; 2019 Dec; 104(12):6101-6115. PubMed ID: 31373627 [TBL] [Abstract][Full Text] [Related]
4. Prevalence and Risk Factors of Early Endocrine Disorders in Childhood Brain Tumor Survivors: A Nationwide, Multicenter Study. Clement SC; Schouten-van Meeteren AY; Boot AM; Claahsen-van der Grinten HL; Granzen B; Sen Han K; Janssens GO; Michiels EM; van Trotsenburg AS; Vandertop WP; van Vuurden DG; Kremer LC; Caron HN; van Santen HM J Clin Oncol; 2016 Dec; 34(36):4362-4370. PubMed ID: 27998218 [TBL] [Abstract][Full Text] [Related]
5. High prevalence of early hypothalamic-pituitary damage in childhood brain tumor survivors: need for standardized follow-up programs. Clement SC; Meeteren AY; Kremer LC; van Trotsenburg AS; Caron HN; van Santen HM Pediatr Blood Cancer; 2014 Dec; 61(12):2285-9. PubMed ID: 25131941 [TBL] [Abstract][Full Text] [Related]
6. Body mass index at diagnosis of a childhood brain tumor; a reflection of hypothalamic-pituitary dysfunction or lifestyle? van Roessel IMAA; van Schaik J; Meeteren AYNS; Boot AM; der Grinten HLC; Clement SC; van Iersel L; Han KS; van Trotsenburg ASP; Vandertop WP; Kremer LCM; van Santen HM Support Care Cancer; 2022 Jul; 30(7):6093-6102. PubMed ID: 35416504 [TBL] [Abstract][Full Text] [Related]
7. Hypothalamic-pituitary dysfunction in survivors of childhood brain tumors in Prasat Neurological Institute. Lusawat A; Dhiravibulya K; Thammongkol S; Vanavanan S; Mahachoklertwattana P J Med Assoc Thai; 2010 Jan; 93(1):38-47. PubMed ID: 20196409 [TBL] [Abstract][Full Text] [Related]
8. Endocrine disorders among long-term survivors of childhood head and neck rhabdomyosarcoma. Clement SC; Schoot RA; Slater O; Chisholm JC; Abela C; Balm AJM; van den Brekel MW; Breunis WB; Chang YC; Davila Fajardo R; Dunaway D; Gajdosova E; Gaze MN; Gupta S; Hartley B; Kremer LCM; van Lennep M; Levitt GA; Mandeville HC; Pieters BR; Saeed P; Smeele LE; Strackee SD; Ronckers CM; Caron HN; van Santen HM; Merks JHM Eur J Cancer; 2016 Feb; 54():1-10. PubMed ID: 26707591 [TBL] [Abstract][Full Text] [Related]
9. Hypothalamic-Pituitary and Growth Disorders in Survivors of Childhood Cancer: An Endocrine Society Clinical Practice Guideline. Sklar CA; Antal Z; Chemaitilly W; Cohen LE; Follin C; Meacham LR; Murad MH J Clin Endocrinol Metab; 2018 Aug; 103(8):2761-2784. PubMed ID: 29982476 [TBL] [Abstract][Full Text] [Related]
10. Antibodies Against Hypothalamus and Pituitary Gland in Childhood-Onset Brain Tumors and Pituitary Dysfunction. Patti G; Calandra E; De Bellis A; Gallizia A; Crocco M; Napoli F; Allegri AME; Thiabat HF; Bellastella G; Maiorino MI; Garrè ML; Parodi S; Maghnie M; di Iorgi N Front Endocrinol (Lausanne); 2020; 11():16. PubMed ID: 32132974 [No Abstract] [Full Text] [Related]
14. Growth hormone deficiency and other endocrinopathies after childhood brain tumors: results from a close follow-up in a cohort of 242 patients. Maciel J; Dias D; Cavaco D; Donato S; Pereira MC; Simões-Pereira J J Endocrinol Invest; 2021 Nov; 44(11):2367-2374. PubMed ID: 33683662 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of Endocrine Disorders in Childhood Brain Tumor Survivors in South Korea. Heo J; Lee HS; Hwang JS; Noh OK; Kim L; Park JE In Vivo; 2019; 33(6):2287-2291. PubMed ID: 31662569 [TBL] [Abstract][Full Text] [Related]